IGBA

International Generic and Biosimilar medicines Association. IGBA works to improve global patient access to quality-assured, safe and cost-effective medicines.

[FDA Drugs and Biologics @FDADrugs]

📢 Join FDA's Dr. Sarah Yim during #GlobalBiosimilarsWeek for Streamlining the Regulatory Process: Advancing Access to Biosimilars webinar, taking place Nov 13: https://t.co/k6hkNeMyYr

This event is presented by @IGBAmedicines and hosted by @BiosimCenter.

[Biosimilars Canada | Biosimilaires Canada @CDNBiosimilars]

In this new LinkedIn article, our President Jim Keon shares his reflections on the biosimilar transition or "switching" policies adopted by public drug plans in Canada over the past five years: https://t.co/PTdwipUQ0V

#GlobalBiosimilarsWeek #GBW24

[Biosimilars Canada | Biosimilaires Canada @CDNBiosimilars]

Notre président Jim Keon partage ses réflexions sur la transition vers les biosimilaires ou les politiques de « substitution » adoptées par les régimes publics d'assurance-médicaments au Canada au cours des cinq dernières années: https://t.co/FaZlLfqA0W

#GBW24

[JackLeckerman @JackLeckerman]

This #GlobalBiosimilarsWeek let's celebrate the impact of biosimilars on healthcare across Latin America and globally🌎 Join the discussion at the Biosimilars LatAm - Mexico 2024 forum.

REGISTER NOW ➡https://t.co/q2tbXPmtvq

[Global Colon Cancer Association @GlobalCRC]

It’s Global Biosimilars Week! Biosimilar medicines play an important role in access to biologic treatments for colorectal cancer.
https://t.co/rBB0UgsbqA
#GlobalBiosimilarsWeek #colorectalcancer

[JackLeckerman @JackLeckerman]

#GlobalBiosimilarsWeek is here! Promising a wealth of valuable insights, we invite you to be part of this experience focused on Advancing Access to Biosimilars. Join the webinar presented by #IGBA and hosted by
@BiosimCenter
link here 👉 https://t.co/kWsJ9KK3L2… #GBW2024

[CenterForBiosimilars @BiosimCenter]

🌍💊 #GlobalBiosimilarsWeek highlights the power of biosimilars to cut health care costs and expand access. Realizing this potential needs urgent policy reform, market competition, and better education. Let's make health care affordable for all!

https://t.co/qJivxLzFiS

[Festival of Biologics @festofbiologics]

From #festivalofbiologics, we have established the importance of Biosimilars in the industry. #Biosimilars are the key to building a better future for patients around the globe. Find out more about biosimilars at https://t.co/UlVQF6U53H

#GlobalBiosimilarsWeek

[Festival of Biologics @festofbiologics]

Join our partner #GlobalBiosimilarsWeek on November 11-15, 2024!

This year, they will be focusing on Advancing Access to Biosimilars, helping more people live healthier lives worldwide. Find out more now at https://t.co/UlVQF6U53H

[IGBA @IGBAmedicines]

Imagine being denied a life-saving medicine.

By making treatment more affordable, #Generic and #Biosimilar medicines can help prevent such a problem, changing the lives of people across the globe.

For how we ensure access to these quality-assured medicines, visitImagine being denied a life-saving medicine.

By making treatment more affordable, #Generic and #Biosimilar medicines can help prevent such a problem, changing the lives of people across the globe.

For how we ensure access to these quality-assured medicines, visit:

[IGBA @IGBAmedicines]

In the US alone, savings from #Generic and #Biosimilar medicines reached more than $2.9 trillion over the last 10 years.

This is the value generated by investing in generic uptake.

For how we can continue to benefit from these vital medicines, visitIn the US alone, savings from #Generic and #Biosimilar medicines reached more than $2.9 trillion over the last 10 years.

This is the value generated by investing in generic uptake.

For how we can continue to benefit from these vital medicines, visitIn the US alone, savings from #Generic and #Biosimilar medicines reached more than $2.9 trillion over the last 10 years.

This is the value generated by investing in generic uptake.

For how we can continue to benefit from these vital medicines, visitIn the US alone, savings from #Generic and #Biosimilar medicines reached more than $2.9 trillion over the last 10 years.

This is the value generated by investing in generic uptake.

For how we can continue to benefit from these vital medicines, visit:

[IGBA @IGBAmedicines]

What if we could empower physicians to treat more patients and prescribe more effective medicines?

Availability of quality-assured #Generic and #Biosimilar medicines can do just that.

To see how we can help maximise prescribers’ budgets, visitWhat if we could empower physicians to treat more patients and prescribe more effective medicines?

Availability of quality-assured #Generic and #Biosimilar medicines can do just that.

To see how we can help maximise prescribers’ budgets, visit:

[IGBA @IGBAmedicines]

Without additional cost how do we improve access to life-changing medicines across the globe?

One answer is competition from quality assured #Generic and #Biosimilar medicines.

For how we ensure the availability of these vital medicines, visitWithout additional cost how do we improve access to life-changing medicines across the globe?

One answer is competition from quality assured #Generic and #Biosimilar medicines.

For how we ensure the availability of these vital medicines, visitWithout additional cost how do we improve access to life-changing medicines across the globe?

One answer is competition from quality assured #Generic and #Biosimilar medicines.

For how we ensure the availability of these vital medicines, visit:

[IGBA @IGBAmedicines]

On this #WorldIPDay, IGBA wants to share a message with you: a balanced IP system is our compass. Let’s celebrate the harmonious blend of innovation and accessibility. Together, we can save lives! #Innovate #Access #Balance

[IFPMA @IFPMA]

Together with the @Selfcarefed_org and the @IGBAmedicines, we welcome the #EB154 report on #NCDs. Prevention, treatment, diagnosis & care must be prioritized in essential benefits packages for NCDs, with primary healthcare as a cornerstone of #UHC.

[IGBA @IGBAmedicines]

IGBA is pleased to join private sector health partners to deliver a statement to the #WHO #EB154 on the importance of combating (#NCDs), contributing to health improvements for people worldwide.

For the statement see: https://t.co/ECVVqNcpMx

[IGBA @IGBAmedicines]

IGBA Secretary General Susana Almeida along with IGBA representatives James Pfitzer from @ViatrisInc and Oliver Hess, MBA from @Sandoz_Global are attending the EB on behalf of our organization. Read more about IGBA’s perspectives on this meeting here: https://t.co/73QJcvPMr9

[IGBA @IGBAmedicines]

IGBA Press Release: IGBA announces leadership change

Read the full press release here: https://t.co/FjhrKP4TbK

#generics #biosimilars #biosimilarmedicines #accessforall

[IGBA @IGBAmedicines]

IGBA Press Release: Vinita Gupta and Lucas Sigman appointed 2024 Chair and Vice-Chair of the IGBA CEO Advisory Committee

Read the full press release here: https://t.co/wZTqf2KDKO

#generics #biosimilars #biosimilarmedicines #accessforall

[IGBA @IGBAmedicines]

Welcome to our newest followers @survivornetca and @StanMehr